3i, LP 13D and 13G filings for CNBX Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:06 pm Purchase |
2024-12-31 | 13G | CNBX Pharmaceuticals Inc. CNBX |
3i, LP | 3,412,557 9.900% |
72,129 (+2.16%) |
Filing |
| 2024-11-14 4:12 pm Purchase |
2024-09-30 | 13G | CNBX Pharmaceuticals Inc. CNBX |
3i, LP | 3,340,428 9.900% |
20,637 (+0.62%) |
Filing |
| 2024-02-13 4:27 pm Purchase |
2023-12-31 | 13G | CNBX Pharmaceuticals Inc. CNBX |
3i, LP | 3,319,791 9.900% |
3,080,811 (+1289.15%) |
Filing |
| 2023-03-06 5:03 pm Purchase |
2022-11-11 | 13G | CNBX Pharmaceuticals Inc. CNBX |
3i, LP | 238,980 9.980% |
238,980 (New Position) |
Filing |